News
-
-
-
PRESS RELEASE
Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research updates BUY recommendation for MaaT Pharma SACA, citing successful €9.1m capital raise with strong investor support for lead drug Xervyteg. Company well-positioned for commercialization -
-
-
-
-
-
-
PRESS RELEASE
Ageing, AI and the revival of industrial policy – structural regime shifts redefine global economy, says Swiss Re Institute
Swiss Re Institute predicts global economy shift with focus on ageing, AI, and industrial policy. Forecasted stability in GDP growth and insurance premium growth by 2027